RxDoctor Payments Data

Elisa Thompson

Nurse Practitioner · Edmond, OKNPI 1467791848

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,375 of the $9,380 with a category attached, or 89.3%. 27 manufacturers reported payments, led by AstraZeneca at 27.1% of the total. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,380in general payments, 2019–2025

Across 268 payments — averaging $35.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Genentech USA, Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$793
  • Amgen$675
  • GSK$674
  • Genentech, Inc.$535
  • plus $3K from 21 others

What the payments were for

  • Consulting fees$8759%
  • Food & beverage$8,37589%
  • Education$1301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,380 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.

See all nurse practitioner providers in Oklahoma

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$21,203
Advair HfaFluticasone Propion/Salmeterol28$11,602
Breo ElliptaFluticasone/Vilanterol15$7,239
Epinephrine26$4,625
Ipratropium Bromide40$1,747
Montelukast Sodium81$1,515
Azelastine Hcl35$1,255
Wixela InhubFluticasone Propion/Salmeterol17$1,184
Albuterol Sulfate HfaAlbuterol Sulfate25$615
Fluticasone Propionate36$510
Levocetirizine Dihydrochloride14$215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$674$28,44341 claims
Hikma Pharmaceuticals USAEpinephrine$79$4,62526 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 824 nurse practitioner providers in Oklahoma.

Other nurse practitioner in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →